FAD-YOLO: a lightweight feature-refined and task-aligned framework for AIS-MIA discrimination on pulmonary CT
Jinghui Chen1, Tao Yang1, Zhipeng Sun1
1The First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
This study introduces FAD-YOLO, a novel deep learning model for detecting early lung cancers like adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA). FAD-YOLO offers high accuracy and a lightweight design, aiding radiologists in diagnosing these conditions on CT scans.
Area of Science:
- Medical Imaging
- Computer Vision
- Artificial Intelligence
Background:
- Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) present as ground-glass nodules (GGNs) on CT scans.
- The low contrast, blurred boundaries, and variable appearance of GGNs challenge automated detection systems.
Purpose of the Study:
- To develop a lightweight yet accurate deep learning framework for detecting AIS and MIA.
- To improve the detection of challenging ground-glass nodules (GGNs) in pulmonary computed tomography (CT) scans.
Main Methods:
- Proposed FAD-YOLO (Feature-refinement, Alignment, and Dynamic-sampling YOLO) framework, building upon YOLO12n.
- Introduced three key modules: A2C2f-FRFN for feature refinement, DySample for dynamic upsampling, and TADDH for task-aligned detection.
Main Results:
- FAD-YOLO achieved high precision (93.8%) and recall (93.4%) on an internal test set.
- The model demonstrated comparable or superior performance to existing detectors (YOLOv5n, YOLOv8n, YOLO11n, RT-DETR) with significantly fewer parameters.
- Achieved strong results (mAP@50 = 91.7%) on an external dataset without fine-tuning.
Conclusions:
- FAD-YOLO offers a balanced solution for accuracy, lightweight design, and cross-dataset generalization.
- The model shows potential as an assistive tool for radiologists in AIS/MIA discrimination, especially on resource-constrained devices.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema
Other Pulmonary Disorders

